NCT03890809View on ClinicalTrials.gov

An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 26, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Liver DysfunctionHealthy Volunteers
Interventions
DRUG

BMS-986165

Oral administration

Trial Locations (4)

3529

Clinical Research Unit Hungary, Miskolc

4043

Kenezy Gyula Korhaz es Rendelointezet, Debrecen

170 00

Pharmaceutical Research Associates CZ, s.r.o, Prague

831 01

Local Institution, Bratislava

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY